Parallax Volatility Advisers, L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,340,000
-44.1%
33,600
-36.3%
0.00%
-50.0%
Q2 2021$2,396,000
+17.9%
52,766
-58.2%
0.00%0.0%
Q1 2019$2,032,000
+1538.7%
126,200
+1385.8%
0.00%
Q4 2018$124,000
-81.6%
8,494
-78.8%
0.00%
-100.0%
Q2 2018$675,000
-95.5%
40,000
-94.8%
0.00%
-95.0%
Q1 2018$14,957,000
+66.8%
763,500
+72.4%
0.02%
+53.8%
Q4 2017$8,969,000
-12.0%
442,770
-24.6%
0.01%
-23.5%
Q3 2017$10,197,000
+377.4%
587,000
+252.3%
0.02%
+325.0%
Q2 2017$2,136,000
-0.7%
166,600
+0.4%
0.00%
-20.0%
Q1 2017$2,151,000
+222.5%
165,929
+145.8%
0.01%
+400.0%
Q4 2016$667,000
-69.1%
67,500
-73.0%
0.00%
-75.0%
Q2 2016$2,158,000
-40.5%
250,000
-34.7%
0.00%
-50.0%
Q1 2016$3,628,000
+719.0%
383,100
+1060.9%
0.01%
+700.0%
Q3 2015$443,000
-83.8%
33,000
-72.8%
0.00%
-83.3%
Q2 2015$2,739,000
+593.4%
121,300
+203.2%
0.01%
+200.0%
Q2 2014$395,00040,0000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders